State KS
Clinical Trials in Kansas
Recruiting clinical trials with at least one study location in Kansas. Data updated daily from ClinicalTrials.gov.
Top Conditions in Kansas
NCT03794466 N/A
Recruiting
Quantify the Degree of Pain Relief of Pelvic Congestion Syndrome Following Gonad...
Condition
Pelvic Congestive Syndrome
Enrollment
30 pts
Location
United States
Sponsor
University of Kansas Medical C
NCT06679985 Phase 2
Recruiting
A Trial of Casdozokitug in Combination With Toripalimab Plus Bevacizumab in Part...
Condition
Hepatocellular Carcinoma
Enrollment
72 pts
Location
United States, Australia, Canada
Sponsor
Coherus Oncology, Inc.
NCT06802406 N/A
Recruiting
Nutrition OUtReach In Systems of Healthcare
Condition
ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
Enrollment
210 pts
Location
United States
Sponsor
University of Kansas Medical C
NCT05913908 N/A
Recruiting
EFS of the DUO System for Tricuspid Regurgitation
Condition
Tricuspid Regurgitation
Enrollment
15 pts
Location
United States, Poland
Sponsor
CroiValve Limited
NCT06075628 N/A
Recruiting
Long-Term Outcomes of LAA Contrast Flow in CT Scans After Endocardial LAA Closur...
Condition
Atrial Fibrillation
Enrollment
100 pts
Location
United States
Sponsor
Kansas City Heart Rhythm Resea
NCT03723928 N/A
Recruiting
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Re...
Condition
Anatomic Stage IV Breast Cancer AJCC v8
Enrollment
739 pts
Location
United States, Guam, Puerto Rico
Sponsor
SWOG Cancer Research Network
NCT06252038 N/A
Recruiting
Rural Alliance for Diabetes Prevention
Condition
PreDiabetes
Enrollment
160 pts
Location
United States
Sponsor
University of Kansas Medical C
NCT06552416 Phase 1
Recruiting
Safety of MT-401-OTS in Patients With Relapsed AML or MDS
Condition
Acute Myeloid Leukemia, in Relapse
Enrollment
40 pts
Location
United States
Sponsor
Marker Therapeutics, Inc.
NCT05462106 Phase 1, Phase 2
Recruiting
A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down S...
Condition
Amyloid Plaque
Enrollment
176 pts
Location
United States, Spain, United Kingdom
Sponsor
AC Immune SA
NCT06475989 Phase 3
Recruiting
Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer
Condition
Refractory Differentiated Thyroid Gland Carcinoma
Enrollment
264 pts
Location
United States
Sponsor
ECOG-ACRIN Cancer Research Gro
NCT06121297 Phase 1, Phase 2
Recruiting
RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of C...
Condition
Systemic Lupus Erythematosus
Enrollment
28 pts
Location
United States, Canada, Spain
Sponsor
Cabaletta Bio
NCT05918861 Phase 3
Recruiting
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Rece...
Condition
Acute Coronary Syndrome
Enrollment
2,000 pts
Location
United States, Canada, Puerto Rico
Sponsor
DalCor Pharmaceuticals
NCT06498635 Phase 3
Recruiting
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After ...
Condition
Lung Non-Small Cell Carcinoma
Enrollment
306 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT07093580 Phase 1
Recruiting
Study of S-892216 Long-acting Injectable (LAI) in Healthy Adult Participants
Condition
Healthy Participants
Enrollment
98 pts
Location
United States
Sponsor
Shionogi
NCT06225596 Phase 2, Phase 3
Recruiting
Study BT8009-230 in Participants With Locally Advanced or Metastatic Urothelial ...
Condition
Metastatic Urothelial Cancer
Enrollment
956 pts
Location
United States, Argentina, Australia
Sponsor
BicycleTx Limited
NCT03493425 Phase 2
Recruiting
Chemotherapy Before Surgery and Radiation Therapy or Surgery and Radiation Thera...
Condition
Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7
Enrollment
82 pts
Location
United States
Sponsor
ECOG-ACRIN Cancer Research Gro
NCT03435796 Phase 2, Phase 3
Recruiting
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Condition
Neoplasms
Enrollment
1,541 pts
Location
United States, Australia, Austria
Sponsor
Celgene
NCT03907046 Phase 3
Recruiting
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
Condition
Intracerebral Hemorrhage
Enrollment
700 pts
Location
United States
Sponsor
Yale University
NCT03802851 N/A
Recruiting
HoLEP Prior to Radiation Therapy for Patients With LUTS/Retention and Concurrent...
Condition
Prostate Cancer
Enrollment
30 pts
Location
United States
Sponsor
University of Kansas Medical C
NCT06064695 N/A
Recruiting
Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Myas...
Condition
Generalized Myasthenia Gravis
Enrollment
16 pts
Location
United States
Sponsor
University of Missouri-Columbi
NCT05174169 Phase 2, Phase 3
Recruiting
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Condition
Stage III Colon Cancer
Enrollment
1,912 pts
Location
United States, Canada, Puerto Rico
Sponsor
NRG Oncology
NCT05668741 Phase 1, Phase 2
Recruiting
A Phase 1/2 Study of VX-522 in Participants With Cystic Fibrosis (CF)
Condition
Cystic Fibrosis
Enrollment
39 pts
Location
United States, Australia, Belgium
Sponsor
Vertex Pharmaceuticals Incorpo
NCT03127631 N/A
Recruiting
A RAndomizeD Intervention for Cardiovascular and Lifestyle Risk Factors in Prost...
Condition
Prostate Cancer
Enrollment
6,000 pts
Location
United States, Australia, Brazil
Sponsor
McMaster University
NCT05304767 Phase 3
Recruiting
An Extension Study to Assess Long-Term Safety and Tolerability of Adjunctive Kar...
Condition
Schizophrenia
Enrollment
280 pts
Location
United States, Bulgaria, Czechia
Sponsor
Karuna Therapeutics, Inc., a B
NCT02302742 N/A
Recruiting
Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer ...
Condition
Breast Cancer
Enrollment
1,500 pts
Location
United States
Sponsor
University of Kansas Medical C